Inventor profile of:

Raymond Kaempfer

City:

Jerusalem

Country:

Israel

Published Applications:

11

Last publication date:

2020-09-03

Top Assignees for applications by Raymond Kaempfer

The entities that hold a legal rights for patent applications filed by inventor Kaempfer Raymond:

Recent patent applications by Kaempfer Raymond

Raymond Kaempfer from Jerusalem, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-09-03
US20200276262A1
Human necessities

Peptides for use in the treatment of viral infections

#2 | 2020-05-14
US20200148741A1
Chemistry; metallurgy

Isolated peptides derived from the B7 ligand dimer interface and uses thereof

#3 | 2018-08-02
US20180215804A1
Chemistry; metallurgy

Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through CD28

#4 | 2018-02-15
US20180044400A1
Chemistry; metallurgy

Isolated peptides derived from the B7 ligand dimer interface and uses thereof

#5 | 2016-10-06
US20160289295A1
Chemistry; metallurgy

Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through CD28

#6 | 2014-11-13
US20140336359A1
Chemistry; metallurgy

Synthetic peptides for treatment of bacterial infections

#7 | 2014-01-09
US20140011731A1
Chemistry; metallurgy

Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof

#8 | 2007-03-13
US9150947
-

Broad spectrum pyrogenic exotoxins antagonists and vaccines

#9 | 2006-10-05
US20060222650A1
Chemistry; metallurgy

Broad spectrum pyrogenic antagonists and vaccines directed against pyrogenic exotoxins

#10 | 2006-05-23
US9801371
-

Regulation of gene expression through manipulation of mRNA splicing and its uses

#11 | 2005-09-01
US20050191296A1
Chemistry; metallurgy

Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof

InventorID:

606300 ⎘